COMP <GO>
IQV vs INCY // 10Y YIELD & FRED MACRO BETA
IQVIA Holdings Inc. (NYSE) VS. Incyte Corp. (NASDAQ) • 15-METRIC TALLY: IQV 3
— INCY 9
▲ 10Y YIELD & FRED MACRO BETA LEADER: IQV
LAST: $267.33 (-2.81%) • MKT CAP: $45.33B
macro-sensitivity
1.16
LAST: $120.39 (+3.07%) • MKT CAP: $23.68B
macro-sensitivity
1.01
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IQV VS. INCY)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | IQV | INCY | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 92.80% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.40% | 42.40% | -33.00 | INCY | /roic <GO> |
| EV/EBITDA & P/E Valuation | 20.4x | 12.5x | +7.90 | INCY | /valuation <GO> |
| Free Cash Flow Yield | 4.24% | 4.99% | -0.75 | INCY | /fcf-yield <GO> |
| Operating Margin | 13.40% | 29.50% | -16.10 | INCY | /operating-margins <GO> |
| Net Profit Margin | 8.30% | 25.00% | -16.70 | INCY | /net-margins <GO> |
| Revenue Growth (YoY) | 5.90% | 21.20% | -15.30 | INCY | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.22 | 10.04 | -7.82 | INCY | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 9/9 | -3.00 | INCY | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 55.7 | 50.0 | +5.70 | IQV | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 1.16 | 1.01 | +0.15 | IQV | /macro-sensitivity <GO> |
| Forward P/E Multiple | 31.0x | 15.5x | +15.50 | INCY | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $45.33B | $23.68B | $21.65B | IQV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | IQV REV | INCY REV | IQV GROSS % | INCY GROSS % | IQV FCF | INCY FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $16.31B | $5.14B | — | 92.8% | $1.92B | $1.18B |
| FY 2024 | $15.40B | $4.24B | — | 92.6% | $2.02B | $144.5M |
| FY 2023 | $14.98B | $3.70B | — | — | $1.47B | $330.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IQV // BETA 1.16
INCY // BETA 1.01